The AST/ALT ratio, representing simultaneous changes in AST and ALT levels, is a widely adopted marker of liver fibrosis, and is also associated with obesity, hyperglycemia, insulin resistance and metabolic syndrome (12, 13, 14, 15). This evidence concerns the gene GPT and metabolic syndrome.